Table 2 Clinicopathological characteristics of RCC patients in training set
From: A novel nine-microRNA-based model to improve prognosis prediction of renal cell carcinoma
Characteristics (451) | Number (high/low) | Percentage (%) | p-Value (Log-rank (Mantel-Cox) test) |
|---|---|---|---|
Age (years) | |||
 < 60 | 112/103 | 47.67% | <0.0001 |
 ≥ 60 | 113/123 | 52.33% | <0.0001 |
Pathological stage | |||
 I–II | 122/171 | 64.97% | 0.0004 |
 III–IV | 98/39 | 30.38% | 0.0026 |
 NA | 5/16 | 4.65% |  |
T stage | |||
 1-2 | 130/185 | 69.84% | 0.0003 |
 3-4 | 94/40 | 29.71% | 0.0001 |
 TX | 0/2 | 4.5% |  |
N stage | |||
 0-1 | 114/77 | 42.35% | <0.0001 |
 2 | 2/1 | 0.67% |  |
 NX | 109/147 | 57.76% |  |
 NA | 0/1 | 0.22% |  |
M stage | |||
 0 | 32/97 | 28.6% | <0.0001 |
 1 | 4/0 | 0.89% |  |
 MX | 17/31 | 10.64% |  |
 NA | 172/98 | 59.87% |  |
Age | |||
 Male | 155/152 | 67.07% | ns |
 Female | 71/73 | 31.93% | ns |